A pilot clinical study of VAL-413 (Orotecan (R), oral irinotecan HCl) in patients with recurrent pediatric solid tumors.James Geller, Patrick Thompson,Javier Oesterheld,Dennis M. Brown,Jeffrey Bacha,Sarath Kanekal,Lorena Lopez,Markos Leggas,Neil Sankar,Noymi Yam,Lars M. WagnerCANCER RESEARCH(2022)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要